Fdg pet in the diagnosis of hilar cholangiocarcinoma

Nuclear Medicine Communications

Volumn 22, Issue 12, 2001, Pages 1277-1285

  Fritscher Ravens, A ^a   Bohuslavizki, K H ^a   Broering, D C ^a   Jenicke, L ^a   SchAFER H ^a   Buchert, R ^a   Rogiers, X ^a   Clausen, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cholangiocarcinoma; Fluorodeoxyglucose; Histopathology; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE; IOPAMIDOL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MORBIDITY; MORTALITY; POSITRON EMISSION TOMOGRAPHY; RELIABILITY;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035203796     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200112000-00002     Document Type: Review

References (40)

1. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230: 663-671.
2. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808-819.
3. Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536-542.
4. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38.
5. Blumgart LH, Benjamin IS. Liver resection for bile duct cancer. Surg Clin North Am 1989; 69: 323-337.
6. Ferrari Junior AP, Lichtenstein DR, Slivka A, Chang C, Carr-Locke DL. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc 1994; 40: 140-145.
7. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999; 31: 712-717.
8. Howell DA, Beveridge RP, Bosco J, Jones M. Endoscopic needle aspiration biopsy at ERCP in the diagnosis of biliary strictures. Gastrointest Endosc 1992; 38: 531-535.
9. Kurzawinski T, Deery A, Davidson BR. Diagnostic value of cytology for biliary stricture. Br J Surg 1993; 80: 414-421.
10. Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997; 40: 671-677.
11. Schoefl R, Haefner M, Wrba F, Pfeffel F, Stain CRP. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenosis. Scand J Gastroenterol 1997; 32: 363-368.
12. Verbeek PC, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112: 866-871.
13. Reske SN. Positron emission tomography in oncology. Dt Ärzteblatt 1998;: B1495-B1497. (In German)
14. Keiding S, Hansen SB, Rasmussen HH, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28: 700-706.
15. Widjaja A, Mix H, Wagner S, et al. Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis. Z Gastroenterol 1999; 37: 731-733.
16. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33: 333-339.
17. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140: 170-178.
18. Bleckmann C, Buchert R, Schulte U, et al. Onko-PET: lesion detection by computer display versus standardized documentation on film. Nuklearmedizin 1999; 38: 56-60.
19. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-475.
20. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628-638.
21. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15: 947-954.
22. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161: 57-63.
23. Scudera PL, Koizumi J, Jacobson IM. Brush cytology evaluation of lesions encountered during ERCP. Gastrointest Endosc 1990; 36: 281-284.
24. Venu RP, Geenen JE, Kini M, et al. Endoscopic retrograde brush cytology. A new technique. Gastroenterology 1990; 99: 1475-1479.
25. Choi BI, Han JK, Kim YI, et al. Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging 1994; 19: 43-46.
26. Choi BI, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: comparative study with sonography and CT. Radiology 1989; 172: 689-692.
27. Hann LE, Greatrex KV, Bach AM, Fong Y, Blumgart LH. Cholangiocarcinoma at the hepatic hilus: sonographic findings. Am J Roentgenol 1997; 168: 985-989.
28. Desa LA, Akosa AB, Lazzara S, Domizio P, Krausz T, Benjamin IS. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut 1991; 32: 1188-1191.
29. Fritscher-Ravens A, Broering DC, Sriram PVJ, et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest Endosc 2000; 52: 534-540.
30. Nesbit GM, Johnson CD, James EM, MacCarty RL, Nagorney DM, Bender CE. Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. Am J Roentgenol 1988; 151: 933-938.
31. Low RN, Sigeti JS, Francis IR, et al. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography. Am J Roentgenol 1994; 162: 315-323.
32. Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. Radiology 1997; 202: 663-669.
33. Lomanto D, Pavone P, Laghi A, et al. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases. Am J Surg 1997; 174: 33-38.
34. Barish MA, Yucel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med 1999; 341: 258-264.
35. Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF. Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Nuklearmedizin 1996;: 42-52. (In German)
36. Berr F, Wiedmann M, Mossner J, Tannapfel A, Schmidt F. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1999; 29: 611-613.
37. Farrell MA, McAdams HP, Herndon JE, Patz Jr EF. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000; 215: 886-890.
38. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 2000; 117: 773-778.
39. Gupta NC, Graeber GM, Rogers 2nd JS, Bishop HA. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 1999; 229: 286-291.
40. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43: 759-770.